The global automated breast ultrasound market size is expected to reach USD 4.49 billion by 2030, expanding at a CAGR of 13.6%, according to a new report by Grand View Research, Inc. The rising incidence of this form of cancer, technological advancement, and various initiatives undertaken to raise awareness regarding cancer across the globe are expected to propel market growth.
Government, non-profit organizations, and various private companies are taking several initiatives to raise cancer awareness among women and men. The aim of these initiatives is to highlight the importance of cancer awareness and raise funds to support research on cancer treatment. For instance, the Estée Lauder Companies organized a breast cancer campaign in 2018 with an aim to inspire women suffering from cancer and to create awareness among people across the globe. This campaign was one of the largest corporate philanthropic initiative and was supported by the company’s employees. Furthermore, this campaign raised around USD 79.0 million, of which more than USD 65.0 million was utilized in 260 medical research grants through the Breast Cancer Research Foundation (BCRF) and in research, medical service, and education.
Such initiatives are expected to boost the demand for various automated ultrasound techniques for the screening of breast cancer, thereby propelling market growth. In addition, increasing prevalence of cancer across the globe is also anticipated to boost the demand for automated ultrasound systems. For instance, as per the Canadian Cancer Society in 2019, breast cancer is the most common cancer among Canadian women. Moreover, favorable reimbursement policies for cancer diagnosis and treatment are also expected to spur market growth.
Hospitals are the largest end users of automated ultrasound systems and this trend is likely to continue over the course of the forecast period. Favorable initiatives by governments and non-profit organizations and introduction of technologically advanced imaging equipment have driven this segment. North America is one of the most prominent markets, owing to high incidence of the chronic disease and growing awareness among patients regarding early screening and diagnosis.
Request a free sample copy or view report summary: Automated Breast Ultrasound Market Report
In terms of revenue, the automated breast ultrasound segment held the largest share in 2023 owing to the rising cases of cancer across the globe
The diagnostics imaging laboratories segment is anticipated to witness the fastest growth rate over the forecast period owing to the increasing number of diagnostic centers and rising demand for imaging techniques for cancer treatment
The Asia Pacific market is expected to witness the fastest growth over the forecast period owing to rising cases of cancer in women
Grand View Research has segmented the global automated breast ultrasound market report based on product, end use, and region:
Automated Breast Ultrasound Product Outlook (Revenue, USD Million, 2018 - 2030)
Automated Breast Volume Scanner
Automated Breast Ultrasound (ABUS)
Automated Breast Ultrasound End Use Outlook (Revenue, USD Million, 2018 - 2030)
Hospital
Diagnostics Imaging Laboratories
Others
Automated Breast Ultrasound Regional Outlook (Revenue, USD Million; 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
MEA
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Automated Breast Ultrasound Market
GE HealthCare.
Koninklijke Philips N.V.
Siemens Healthcare Private Limited
CANON MEDICAL SYSTEMS CORPORATION
TELEMED Medical Systems srl
Hologic, Inc.
SuperSonic Imagine
Lunit Inc.
Delphinus Medical Technologies, Inc.
"The quality of research they have done for us has been excellent..."